Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A Prophylaxis
Open Access
- 17 October 2017
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 9 (4), 47
- https://doi.org/10.3390/pharmaceutics9040047
Abstract
The total body weight-based dosing strategy currently used in the prophylactic treatment of hemophilia A may not be appropriate for all populations. The assumptions that guide weight-based dosing are not valid in overweight and obese populations, resulting in overdosing and ineffective resource utilization. We explored different weight metrics including lean body weight, ideal body weight, and adjusted body weight to determine an alternative dosing strategy that is both safe and resource-efficient in normal and overweight/obese adult patients. Using a validated population pharmacokinetic model, we simulated a variety of dosing regimens using different doses, weight metrics, and frequencies; we also investigated the implications of assuming various levels of endogenous factor production. Ideal body weight performed the best across all of the regimens explored, maintaining safety while moderating resource consumption for overweight and obese patients.Funding Information
- Canadian Institutes of Health Research
This publication has 46 references indexed in Scilit:
- Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parametersHaemophilia, 2013
- Impact of being underweight or overweight on factor VIII dosing in hemophilia A patientsHaematologica, 2013
- The Relationship between Drug Clearance and Body SizeClinical Pharmacokinetics, 2012
- Effect of Obesity on the Pharmacokinetics of Drugs in HumansClinical Pharmacokinetics, 2010
- Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe HemophiliaThe New England Journal of Medicine, 2007
- Pharmacokinetic studies of coagulation factors: relevance of plasma and extracellular volume and body weightHaemophilia, 2006
- Quantification of Lean BodyweightClinical Pharmacokinetics, 2005
- Effects of Obesity on PharmacokineticsClinical Pharmacokinetics, 2000
- Improved cost‐effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia AHaemophilia, 1997
- CALCULATING THE DOSE OF FACTOR VIII IN THE MANAGEMENT OF HAEMOPHILIABritish Journal of Haematology, 1981